登记Id

PA448771

药物名称(英)

capecitabine

通用名称

R340,capecitabine

商品名称

Xeloda

品牌组合

类型(英)

Prodrug

类型

前药

交叉引用

"Canadian Drugs Product Database:02238454","ChEBI:CHEBI:31348","Chemical Abstracts Service:154361-50-9","ChemSpider:54916","ClinicalTrials.gov:NCT00074321","ClinicalTrials.gov:NCT00130936","ClinicalTrials.gov:NCT00235235","ClinicalTrials.gov:NCT00433550","ClinicalTrials.gov:NCT00452673","ClinicalTrials.gov:NCT00559676","ClinicalTrials.gov:NCT00589901","ClinicalTrials.gov:NCT00645866","ClinicalTrials.gov:NCT00660426","ClinicalTrials.gov:NCT00838370","ClinicalTrials.gov:NCT00938470","ClinicalTrials.gov:NCT01158274","ClinicalTrials.gov:NCT01359397","ClinicalTrials.gov:NCT01501669","ClinicalTrials.gov:NCT01641458","ClinicalTrials.gov:NCT01705106","DrugBank:DB01101","FDA Drug Label at DailyMed:a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8","KEGG Compound:C12650","KEGG Drug:D01223","National Drug Code Directory:0004-1100-20","PubChem Compound:60953","PubChem Substance:197173","PubChem Substance:46508686","Therapeutic Targets Database:DAP000761","URL:http://en.wikipedia.org/wiki/Capecitabine"

简化分子线性输入规范

CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O

键

InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1

剂量指南

Yes

外部词汇

"MeSH:C110904(capecitabine)","ATC:L01BC06(capecitabine)","UMLS:C0671970(capecitabine)","RxNorm:194000(capecitabine)","ND

RxNorm 标识符

194000

ATC 标识符

L01BC06

化合物标识符

60953